GleamWall
中文EN

CVRX CVRx, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1235912 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.8%
TTM net income YoY-2.4%
TTM EPS YoY-0.5%
Revenue 3-yr CAGR19.7%
Net income 3-yr CAGR—

Margins

Gross margin86.9%
Operating margin-81.9%
Net margin-88.3%
FCF margin-69.7%
EBITDA margin-80.6%

Returns

ROE-172.2%
ROA-53.5%
ROIC (approx.)-299.0%
Asset turnover0.61x

Leverage & solvency

Liabilities / assets84.2%
Debt / equity4.24x
Current ratio6.80x
Interest coverage-8.03x

Cash quality & payout

Operating cash flow / net income0.78x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$13.83M$15.71M$14.77M$16.02M$14.69M$13.59M$12.35M$15.34M
Cost of revenue$1.83M$1.98M$1.89M$2.20M$1.94M$2.14M$2.04M$2.57M
Gross profit$12.00M$13.72M$12.88M$13.82M$12.75M$11.45M$10.31M$12.77M
R&D expense$2.65M$3.13M$3.08M$3.00M$3.15M$2.47M$2.52M$2.81M
SG&A expense$22.39M$23.62M$21.96M$22.01M$21.88M$23.36M$21.23M$20.24M
Operating income-$13.04M-$13.02M-$12.16M-$11.18M-$12.27M-$14.38M-$13.44M-$10.27M
Interest expense$1.61M$1.58M$1.55M$1.42M$1.48M$1.47M$1.46M$1.52M
Pretax income-$14.16M-$14.04M-$13.12M-$11.94M-$12.87M-$14.74M-$13.77M-$10.72M
Income tax-$1,000$3,000$1,000-$7,000-$3,000-$3,000-$5,000-$71,000
Net income-$14.16M-$14.04M-$13.12M-$11.93M-$12.87M-$14.74M-$13.77M-$10.65M
EBITDA-$12.85M-$12.82M-$11.96M-$11.00M-$12.07M-$14.18M-$13.25M-$10.10M
EPS (basic)-0.52-0.53-0.50—-0.49-0.57-0.53—
EPS (diluted)-0.52-0.53-0.50—-0.49-0.57-0.53—
Weighted avg. shares (diluted)27.25M26.52M26.36M—26.17M26.07M25.88M—
Balance sheet
Cash & equivalents$58.75M$64.59M$72.30M$75.71M$85.12M$95.03M$102.67M$105.93M
Receivables$9.59M$9.40M$9.10M$10.66M$8.21M$7.15M$9.01M$9.27M
Inventory$13.63M$13.03M$12.40M$12.21M$11.39M$11.72M$11.67M$12.11M
Current assets$85.02M$89.49M$96.75M$101.65M$107.89M$116.14M$126.13M$129.81M
PP&E, net$1.94M$2.06M$2.16M$2.24M$2.45M$2.35M$2.44M$2.50M
Total assets$87.61M$92.28M$99.73M$104.79M$111.33M$119.56M$129.59M$133.41M
Current liabilities$12.51M$11.12M$9.49M$13.32M$11.22M$9.69M$8.51M$10.76M
Long-term debt$58.66M$58.57M$58.49M$49.51M$49.45M$49.39M$49.33M$49.27M
Total debt$58.66M$58.57M$58.49M$49.51M$49.45M$49.39M$49.33M$49.27M
Total liabilities$73.79M$72.33M$70.62M$65.47M$63.27M$61.63M$60.23M$62.36M
Shareholders' equity$13.82M$19.95M$29.11M$39.32M$48.05M$57.93M$69.36M$71.06M
Net debt-$91,000-$6.01M-$13.81M-$26.19M-$35.67M-$45.63M-$53.34M-$56.66M
Shares outstanding28.49M26.64M26.43M26.31M26.19M26.15M26.05M25.32M
Cash flow statement
Operating cash flow-$10.90M-$8.83M-$12.16M-$9.76M-$9.71M-$7.94M-$12.77M-$8.01M
Capital expenditure$98,000$112,000$122,000$68,000$295,000$103,000$114,000$52,000
Free cash flow-$10.99M-$8.94M-$12.29M-$9.83M-$10.00M-$8.04M-$12.88M-$8.06M
Investing cash flow-$98,000-$112,000-$122,000-$68,000-$295,000-$103,000-$114,000-$52,000
Financing cash flow$5.16M$1.22M$8.88M$410,000$103,000$392,000$9.62M$13.83M
Depreciation & amortization$200,000$200,000$205,000$185,000$200,000$200,000$184,000$178,000
Stock-based compensation$2.87M$3.66M$2.92M$2.79M$2.89M$2.92M$2.46M$2.69M

Free plan shows the latest 8 periods; Pro shows all 26 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.